Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB13401InvestigationalSmall molecule
Metildigoxin is a digitalis glycoside indicated in the treatment of acute and chronic heart failure. A medication used to treat heart failure.
- Mechanism
- Curator reviewed
Pharmacologically active on Sodium/Potassium Transporting ATPase
- Formula / weight
- C42H66O14 · 794.976 g/mol (avg)
Resolves to
Clinical / RWD
Structure
InChIKey
IYJMSDVSVHDVGT-PEQKVOOWSA-NSMILES[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@]([H])(CC[C@]4(C)[C@@]3([H])C[C@@]([H])(O)[C@]12C)O[C@@]1([H])C[C@]([H])(O)[C@]([H])(O[C@@]2([H])C[C@]([H])(O)[C@]([H])(O[C@@]3([H])C[C@]([H])(O)[C@]([H])(OC)[C@@]([H])(C)O3)[C@@]([H])(C)O2)[C@@]([H])(C)O1)C1=CC(=O)OC1What you can answer from here — as of July 07, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which other approved drugs treat the same conditions as Metildigoxin, and which companies have late-stage candidates in those indications?